glutamic acid has been researched along with Cancer of Skin in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.35) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (17.39) | 29.6817 |
| 2010's | 17 (73.91) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| De Giorgi, V; Gori, A; Massi, D; Pazzagli, M; Pinzani, P; Salvianti, F | 1 |
| Bosenberg, M; Talty, R | 1 |
| Perry, RJ; Rabin-Court, A; Rodrigues, MR; Zhang, XM | 1 |
| Li, S; Liang, C; Nemecio, D; Quach, C; Song, Y | 1 |
| Edmonds, K; Fearfield, L; Gore, M; Larkin, J; Newton-Bishop, J; Sinha, R | 1 |
| D'Alonzo, D; Glatz, K | 1 |
| Botella, L; Callaghan, RC; Cerda-Nicolas, M; Gil-Benso, R; Gonzalez-Darder, J; Lopez-Gines, C; Muñoz-Hidalgo, L; Navarro, L; Quilis, V; San Miguel, T | 1 |
| Benedict, JJ; DeConti, R; Gibney, GT; Gonzalez, RJ; Kudchadkar, RR; McCardle, T; Messina, JL; Sloot, S; Smalley, KS; Sondak, VK; Turner, LM; Weber, JS; Zager, JS | 1 |
| Anniciello, AM; Ascierto, PA; Botti, G; Favoino, E; Feldman, SA; Ferrone, CR; Ferrone, S; Flaherty, KT; Giannarelli, D; Nota, S; Palmieri, G; Pepe, S; Sabbatino, F; Scognamiglio, G; Simeone, E; Villani, V; Wang, Y | 1 |
| Bassett, RL; DeLyria, ES; Hwu, P; Li, C; Li, D; Liu, C; Lu, W; Ma, Q; Overwijk, WW; Thapa, P; Wen, X; Zhou, D | 1 |
| Chen, S; Goydos, JS; Shin, SS; Wall, BA | 1 |
| Chan, JL; Cohen-Solal, KA; Goydos, JS; Le, MN; Merrigan, KT; Nabatian, AS; Rosenberg, SA | 1 |
| Mier, JW; Panka, DJ; Sullivan, RJ | 1 |
| Coral, S; Fratta, E; Maio, M; Parisi, G; Sigalotti, L | 1 |
| Chi, Z; Cui, C; Flaherty, KT; Guo, J; Kong, Y; Li, S; Mao, L; Sheng, X; Si, L; Xu, X | 1 |
| Chen, S; Teh, JL | 1 |
| Ajouaou, A; Dankort, D; Horlings, HM; Kortman, PC; McMahon, M; Meissl, K; Michaloglou, C; Mooi, WJ; Peeper, DS; Possik, PA; Smit, MA; Vredeveld, LC | 1 |
| Gao, H; Gao, L; Gao, W; He, CD; Li, L; Liu, J; Liu, Y; Lu, P; Shan, L; Song, Z; Sun, C; Xu, Y; Zhang, Y; Zou, W | 1 |
| Barany, F; Elenitsas, R; Seykora, J; Turner, DJ; Zirvi, MA | 1 |
| Angel, C; Dobrovic, A; Dowling, JP; Kelly, JW; Liu, W; Magee, J; Mason, G; McArthur, GA; Murray, WK; Trivett, M; Wolfe, R | 1 |
| Chen, S; Goydos, JS; Lee, HJ; Marín, YE; Namkoong, J; Shin, SS; Wall, BA | 1 |
| Haas, HS; Heintz, E; Ingolic, E; Pfragner, R; Schauenstein, K; Schraml, E; Siegl, V | 1 |
| Orten, DK; Owen, MD; Perchellet, JP; Posey, TD; Schneider, BA | 1 |
2 review(s) available for glutamic acid and Cancer of Skin
| Article | Year |
|---|---|
The role of ferroptosis in melanoma.
Topics: Animals; Cell Dedifferentiation; Drug Resistance, Neoplasm; Ferroptosis; Glutamic Acid; Humans; Immune Checkpoint Inhibitors; Iron; Melanoma; Signal Transduction; Skin Neoplasms | 2022 |
Glutamatergic signaling in cellular transformation.
Topics: Animals; Brain; Cell Transformation, Neoplastic; Gene Expression Regulation, Neoplastic; Glutamic Acid; Humans; Melanocytes; Melanoma; Mice; Mice, Transgenic; Receptors, Metabotropic Glutamate; Signal Transduction; Skin Neoplasms | 2012 |
21 other study(ies) available for glutamic acid and Cancer of Skin
| Article | Year |
|---|---|
Evaluation of the liquid biopsy for the detection of BRAFV600E mutation in metastatic melanoma patients.
Topics: Amino Acid Substitution; Biomarkers, Tumor; Circulating Tumor DNA; DNA Mutational Analysis; Feasibility Studies; Glutamic Acid; Humans; Liquid Biopsy; Melanoma; Mutation; Neoplastic Cells, Circulating; Proto-Oncogene Proteins B-raf; Real-Time Polymerase Chain Reaction; Skin Neoplasms; Valine | 2019 |
Obesity-associated, but not obesity-independent, tumors respond to insulin by increasing mitochondrial glucose oxidation.
Topics: Alanine; Breast Neoplasms; Cell Line, Tumor; Citrate (si)-Synthase; Colonic Neoplasms; Female; Gene Expression Regulation; Glucose; Glutamic Acid; Humans; Insulin; Isotope Labeling; Ketone Oxidoreductases; Lymphoma, B-Cell; Male; Melanoma; Mitochondria; Obesity; Organ Specificity; Oxidation-Reduction; Phosphorylation; Prostatic Neoplasms; Receptor, Insulin; Signal Transduction; Skin Neoplasms; Small Cell Lung Carcinoma | 2019 |
Revisiting the role of autophagy in melanoma.
Topics: Amino Acid Substitution; Animals; Autophagy; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Glutamic Acid; Humans; MAP Kinase Signaling System; Melanoma; Proto-Oncogene Proteins B-raf; Signal Transduction; Skin Neoplasms; Valine | 2019 |
Erythema nodosum-like panniculitis in patients with melanoma treated with vemurafenib.
Topics: Adult; Antineoplastic Agents; Diagnosis, Differential; Erythema Nodosum; Female; Glutamic Acid; Humans; Indoles; Male; Melanoma; Middle Aged; Molecular Targeted Therapy; Panniculitis; Point Mutation; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Sulfonamides; Valine; Vemurafenib | 2013 |
Absent response of intracranial melanoma metastases harboring BRAF V600E sequence variation to vemurafenib.
Topics: Aged; Antineoplastic Agents; Brain Neoplasms; Fatal Outcome; Glutamic Acid; Humans; Ileal Neoplasms; Immunohistochemistry; Indoles; Magnetic Resonance Imaging; Male; Melanoma; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Sulfonamides; Treatment Failure; Valine; Vemurafenib | 2013 |
BRAF V600E mutation in two distinct meningeal melanocytomas associated with a nevus of Ota.
Topics: Adolescent; Cell Transformation, Neoplastic; Glutamic Acid; Humans; Male; Melanocytes; Melanoma; Meningeal Neoplasms; Mutation; Nevus of Ota; Proto-Oncogene Proteins B-raf; Signal Transduction; Skin Neoplasms; Valine | 2014 |
BRAF inhibition for advanced locoregional BRAF V600E mutant melanoma: a potential neoadjuvant strategy.
Topics: Amino Acid Substitution; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Female; Follow-Up Studies; Glutamic Acid; Humans; Imidazoles; Indoles; Male; Melanoma; Middle Aged; Molecular Targeted Therapy; Mutation, Missense; Neoadjuvant Therapy; Oximes; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Pyridones; Pyrimidinones; Retrospective Studies; Skin Neoplasms; Sulfonamides; Treatment Outcome; Valine; Vemurafenib | 2016 |
Antitumor Activity of BRAF Inhibitor and IFNα Combination in BRAF-Mutant Melanoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Glutamic Acid; Humans; Immunohistochemistry; Interferon-alpha; MAP Kinase Signaling System; Melanoma; Mice; Mice, Inbred NOD; Mice, SCID; Mutation; Proto-Oncogene Proteins B-raf; Receptor, Interferon alpha-beta; Signal Transduction; Skin Neoplasms; Valine | 2016 |
Synthetic Poly(L-Glutamic Acid)-conjugated CpG Exhibits Antitumor Efficacy With Increased Retention in Tumor and Draining Lymph Nodes After Intratumoral Injection in a Mouse Model of Melanoma.
Topics: Animals; Disease Models, Animal; Drug Delivery Systems; Female; Glutamic Acid; Humans; Injections, Intralesional; Lymph Nodes; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Oligodeoxyribonucleotides; Polymers; Skin Neoplasms; Toll-Like Receptor 9; Tumor Burden | 2017 |
AKT2 is a downstream target of metabotropic glutamate receptor 1 (Grm1).
Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Enzyme Activation; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glutamic Acid; Humans; Melanoma; Mice; Mice, Nude; Proto-Oncogene Proteins c-akt; Receptors, Metabotropic Glutamate; Signal Transduction; Skin Neoplasms | 2010 |
The glutamate release inhibitor Riluzole decreases migration, invasion, and proliferation of melanoma cells.
Topics: Cell Division; Cell Line, Tumor; Cell Movement; Excitatory Amino Acid Antagonists; Extracellular Signal-Regulated MAP Kinases; Glutamic Acid; Humans; Melanoma; Naphthalenes; Neoplasm Invasiveness; Organ Culture Techniques; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptors, Metabotropic Glutamate; Riluzole; Signal Transduction; Skin Neoplasms | 2010 |
An inexpensive, specific and highly sensitive protocol to detect the BrafV600E mutation in melanoma tumor biopsies and blood.
Topics: Amino Acid Substitution; Biopsy; Blood Chemical Analysis; Cell Line, Tumor; Cost-Benefit Analysis; Cytogenetic Analysis; DNA Mutational Analysis; Glutamic Acid; HT29 Cells; Humans; Melanoma; Models, Biological; Proto-Oncogene Proteins B-raf; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity; Skin Neoplasms; Valine | 2010 |
Stability of BRAF V600E mutation in metastatic melanoma: new insights for therapeutic success?
Topics: Amino Acid Substitution; Disease Progression; Glutamic Acid; Humans; Melanoma; Mutation, Missense; Neoplasm Metastasis; Prognosis; Proto-Oncogene Proteins B-raf; Selection, Genetic; Skin Neoplasms; Treatment Outcome; Valine | 2011 |
Prevalence of BRAF V600E mutation in Chinese melanoma patients: large scale analysis of BRAF and NRAS mutations in a 432-case cohort.
Topics: Adult; Aged; Amino Acid Substitution; Asian People; Cohort Studies; DNA Mutational Analysis; Female; Genes, ras; Glutamic Acid; Humans; Male; Melanoma; Middle Aged; Mutation Rate; Mutation, Missense; Prognosis; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Valine | 2012 |
Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis.
Topics: Amino Acid Substitution; Cell Proliferation; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p15; Enzyme Activation; Fibroblasts; Glutamic Acid; Humans; Melanocytes; Melanoma; Nevus; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Skin Neoplasms; Valine | 2012 |
Blocking glutamate-mediated signalling inhibits human melanoma growth and migration.
Topics: Animals; Cell Movement; Cell Proliferation; Chromones; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; HEK293 Cells; Humans; Melanoma; Mice; Mice, Inbred BALB C; Mice, Nude; Microtubule-Associated Proteins; Microtubules; Neoplasm Invasiveness; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Skin Neoplasms; Xenograft Model Antitumor Assays | 2012 |
Detection of the BRAF V600E mutation in melanocytic lesions using the ligase detection reaction.
Topics: Base Sequence; DNA; DNA Mutational Analysis; Dysplastic Nevus Syndrome; Glutamic Acid; Humans; Ligases; Melanocytes; Melanoma; Molecular Sequence Data; Mutation; Nevus; Proto-Oncogene Proteins B-raf; Sensitivity and Specificity; Skin Neoplasms; Valine | 2005 |
Distinct clinical and pathological features are associated with the BRAF(T1799A(V600E)) mutation in primary melanoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine; Child; Female; Gene Frequency; Glutamic Acid; Humans; Male; Melanoma; Middle Aged; Multivariate Analysis; Mutation; Pigmentation; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Threonine; Valine | 2007 |
Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Drug Evaluation, Preclinical; Glutamic Acid; Humans; Melanoma; Mice; Mice, Nude; Mutant Proteins; Receptors, Metabotropic Glutamate; Riluzole; Signal Transduction; Skin Neoplasms; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2007 |
The non-competitive metabotropic glutamate receptor-1 antagonist CPCCOEt inhibits the in vitro growth of human melanoma.
Topics: Antineoplastic Agents; Cell Proliferation; Chromones; Docetaxel; Drug Resistance, Neoplasm; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Melanoma; Receptors, Metabotropic Glutamate; Skin Neoplasms; Taxoids; Tumor Cells, Cultured | 2007 |
Inhibitory effects of glutathione level-raising agents and D-alpha-tocopherol on ornithine decarboxylase induction and mouse skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.
Topics: Amino Acids; Animals; Cysteine; Enzyme Induction; Female; gamma-Glutamyltransferase; Glutamate-Cysteine Ligase; Glutamates; Glutamic Acid; Glutathione; Glycine; In Vitro Techniques; Mice; Ornithine Decarboxylase; Skin; Skin Neoplasms; Tetradecanoylphorbol Acetate; Vitamin E | 1985 |